Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems
- DOI
- 10.3389/fcdhc.2026.1984666
- Published
- 2026-10-20
- Container
- Frontiers in Clinical Diabetes and Healthcare
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fcdhc.2026.1984666,
title = {Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems},
author = {Dan Zhang and Yun Zhao and Haiting Chen and Yang Miao},
year = {2026},
journal = {Frontiers in Clinical Diabetes and Healthcare},
doi = {10.3389/fcdhc.2026.1984666},
url = {https://doi.org/10.3389/fcdhc.2026.1984666}
}RIS
TY - JOUR TI - Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems AU - Dan Zhang AU - Yun Zhao AU - Haiting Chen AU - Yang Miao PY - 2026 JO - Frontiers in Clinical Diabetes and Healthcare DO - 10.3389/fcdhc.2026.1984666 UR - https://doi.org/10.3389/fcdhc.2026.1984666 ER -
APA
Zhang, D., Zhao, Y., Chen, H., & Miao, Y. (2026). Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems. Frontiers in Clinical Diabetes and Healthcare. https://doi.org/10.3389/fcdhc.2026.1984666
Source records
- crossref · retrieved 2026-11-10T10:56:53.983Z